Literature DB >> 8762112

Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy.

T S Saleh1, J B Calixto, Y S Medeiros.   

Abstract

1. The aim of this study was to examine the effect of theophylline, cromolyn and salbutamol, three well-known anti-asthmatic drugs, on the early (4 h) and late (48 h) phases of cell migration and fluid leakage induced by carrageenin in the pleural cavity of mice. 2. In the first set of experiments, animals were pretreated (30 min) with different doses of theophylline (0.5-50 mg kg-1, i.p.), cromolyn (0.02-0.2 mg per pleural cavity) or salbutamol (0.05-50 mg kg-1, i.p.); the total and differential cell content, and also the exudate were analysed 4 h after carrageenin (1%) administration. Afterwards, in order to evaluate the time course effects of these drugs on both phases of the inflammatory reaction, one dose employed in the above protocol was chosen, to pretreat (0.5-24 h) different groups of animals. The studied parameters were evaluated 4 and 48 h after pleurisy induction. 3. Acute administration of theophylline (1-50 mg kg-1, i.p.) cromolyn (0.02-0.2 mg per pleural cavity) and salbutamol (0.5-50 mg kg-1, i.p.), 30 min prior to carrageenin, caused significant inhibition of total cell and fluid leakage in the pleural cavity at 4 h (P < 0.01). All drugs exerted a long-lasting inhibitory effect on both exudation and cell migration (P < 0.01) when administered 0.5-8 h before pleurisy induction. However, the temporal profile of the inhibitory effect induced by these drugs on the first phase of the inflammatory reaction was clearly different. Thus, the inhibitory effect induced by theophylline and cromolyn on exudation was significantly longer (up to 24 h) in comparison to their effects on cell migration (only up to 8 h). In contrast, although salbutamol when administered 30 min before pleurisy induction abolished fluid leakage (P < 0.01), this effect was not sustained in the groups pretreated for 4-8 h. In these latter groups, a significant but much smaller reduction of exudation was observed (P < 0.01), whereas the magnitude of cell migration inhibition did not vary. 4. The second phase (48 h) of the inflammatory reaction induced by carrageenin (1%) was significantly inhibited by cromolyn (0.02 mg per pleural cavity) when this drug was administered 0.5-24 h before pleurisy induction (P < 0.01). Similar results were observed when theophylline (50 mg kg-1, i.p.) was administered 0.5-4 h before the injection of the phlogistic agent (P < 0.01). Treatment of the animals with salbutamol (5 mg kg-1, i.p.), 0.5-24 h before pleurisy induction, did not inhibit either cell migration or fluid leakage. In this condition, a significant increase of these parameters was observed in the group pretreated with salbutamol 8-24 h before pleurisy induction (P < 0.01). 5. These results indicate that theophylline and cromolyn were able to inhibit the early (4 h) and late (48 h) phases of the inflammatory reaction induced by carrageenin in a murine model of pleurisy. Salbutamol was effective only against the early phase. The inhibitory effects of theophylline, cromolyn and salbutamol on the early phase of this inflammatory reaction were long-lasting, although a distinct profile of inhibition was observed among them. These findings confirm and extend previous results described in other models of asthma and support both clinical and experimental evidence suggesting that these anti-asthmatic agents exhibit marked anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762112      PMCID: PMC1909745          DOI: 10.1111/j.1476-5381.1996.tb15472.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  New aspects of the therapeutic potential of theophylline in asthma.

Authors:  R A Pauwels
Journal:  J Allergy Clin Immunol       Date:  1989-02       Impact factor: 10.793

2.  One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists.

Authors:  C P Page
Journal:  Lancet       Date:  1991-03-23       Impact factor: 79.321

Review 3.  A new approach to the treatment of asthma.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 4.  Late asthmatic responses.

Authors:  P M O'Byrne; J Dolovich; F E Hargreave
Journal:  Am Rev Respir Dis       Date:  1987-09

Review 5.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.

Authors:  F E Hargreave; G Ryan; N C Thomson; P M O'Byrne; K Latimer; E F Juniper; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1981-11       Impact factor: 10.793

6.  Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation.

Authors:  M L Kowalski; M Sliwinska-Kowalska; M A Kaliner
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

7.  The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats.

Authors:  D J Schrier; M E Lesch; C D Wright; R B Gilbertsen
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

8.  Effect of theophylline and adenosine on eosinophil function.

Authors:  T Yukawa; C Kroegel; P Chanez; G Dent; D Ukena; K F Chung; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1989-08

9.  Cellular events in the bronchi in mild asthma and after bronchial provocation.

Authors:  R Beasley; W R Roche; J A Roberts; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-03

10.  Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs.

Authors:  K H Banner; C P Page
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more
  29 in total

1.  Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors.

Authors:  J B Pesquero; R C Araujo; P A Heppenstall; C L Stucky; J A Silva; T Walther; S M Oliveira; J L Pesquero; A C Paiva; J B Calixto; G R Lewin; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Croton antisyphiliticus Mart. attenuates the inflammatory response to carrageenan-induced pleurisy in mice.

Authors:  Gustavo Oliveira Dos Reis; Geison Vicente; Francieli Kanumfre de Carvalho; Melina Heller; Gustavo Amadeu Micke; Moacir Geraldo Pizzolatti; Tânia Silvia Fröde
Journal:  Inflammopharmacology       Date:  2013-08-29       Impact factor: 4.473

3.  Anti-inflammatory and antinociceptive activities of the leaf methanol extract of Miconia minutiflora (Bonpl.) DC. and characterization of compounds by UPLC-DAD-QTOF-MS/MS.

Authors:  Aline Stamford S G Gatis-Carrazzoni; Fernanda Virgínia Barreto Mota; Tonny Cley Campos Leite; Tatiane Bezerra de Oliveira; Sandra Cabral da Silva; Isla Vanessa Alves Bastos; Maria Bernadete de Souza Maia; Pedro Silvino Pereira; Pedro Paulo Marcelino Neto; Earl Celestino de Oliveira Chagas; Tania Maria Sarmento Silva; Márcia Silva do Nascimento; Teresinha Gonçalves da Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-13       Impact factor: 3.000

4.  Anti-inflammatory and immunomodulatory effects of Ulomoides dermestoides on induced pleurisy in rats and lymphoproliferation in vitro.

Authors:  Roberto Christ Vianna Santos; Adroaldo Lunardelli; Eduardo Caberlon; Carolina Maria Alves Bastos; Fernanda Bordignon Nunes; Melissa Guerra Simões Pires; Vanderlei Biolchi; Elisiane Lozza Paul; Francesco Breno Campolongo Vieira; Alzira Resende do Carmo Aquino; Elio Corseuil; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2010-06       Impact factor: 4.092

5.  Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.

Authors:  Fernanda da Rocha Lapa; Morgana Duarte da Silva; Daniela de Almeida Cabrini; Adair R S Santos
Journal:  Purinergic Signal       Date:  2012-03-29       Impact factor: 3.765

6.  PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy.

Authors:  Ziliani da Silva Buss; Yara S Medeiros; Tania S Fröde
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

7.  Cyclosporin A inhibits CD11a/CD18 adhesion molecules due to inhibition of TNFalpha and IL-1 beta levels in the mouse model of pleurisy induced by carrageenan.

Authors:  Eduardo Monguilhott Dalmarco; Yara Santos Medeiros; Tânia Silvia Fröde
Journal:  Cell Adh Migr       Date:  2008-10-23       Impact factor: 3.405

8.  Anti-inflammatory and immunomodulatory effects of Baccharis trimera aqueous extract on induced pleurisy in rats and lymphoproliferation in vitro.

Authors:  Elisiane Lozza Paul; Adroaldo Lunardelli; Eduardo Caberlon; Cristiane Bernardes de Oliveira; Roberto Christ Vianna Santos; Vanderlei Biolchi; Carolina Maria Alves Bastos; Karla Barbosa Moreira; Fernanda Bordignon Nunes; Grace Gosmann; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

9.  Jungia sellowii suppresses the carrageenan-induced inflammatory response in the mouse model of pleurisy.

Authors:  Marina Nader; Geison Vicente; Julia Salvan da Rosa; Tamires Cardoso Lima; Alyne Machado Barbosa; Alan Diego Conceição Santos; Andersson Barison; Eduardo Monguilhott Dalmarco; Maique Weber Biavatti; Tânia Silvia Fröde
Journal:  Inflammopharmacology       Date:  2014-08-29       Impact factor: 4.473

10.  Grape seed proanthocyanidin extract protects against carrageenan-induced lung inflammation in mice through reduction of pro-inflammatory markers and chemokine expressions.

Authors:  Sheikh Fayaz Ahmad; Khairy M A Zoheir; Hala E Abdel-Hamied; Sabry M Attia; Saleh A Bakheet; Abdelkader E Ashour; Adel R A Abd-Allah
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.